| Primary |
| Bipolar Disorder |
28.4% |
| Depression |
11.8% |
| Schizophrenia |
10.7% |
| Anxiety |
5.7% |
| Psychotic Disorder |
5.0% |
| Schizoaffective Disorder |
4.7% |
| Bipolar I Disorder |
4.4% |
| Ill-defined Disorder |
4.1% |
| Hypertension |
3.5% |
| Sleep Disorder |
2.8% |
| Affective Disorder |
2.5% |
| Drug Use For Unknown Indication |
2.5% |
| Major Depression |
2.1% |
| Insomnia |
2.0% |
| Mania |
1.9% |
| Diabetes Mellitus |
1.6% |
| Obsessive-compulsive Disorder |
1.6% |
| Agitation |
1.6% |
| Blood Cholesterol Increased |
1.5% |
| Attention Deficit/hyperactivity Disorder |
1.5% |
|
| Tardive Dyskinesia |
15.3% |
| Weight Increased |
9.5% |
| Tremor |
9.2% |
| Somnolence |
8.6% |
| Dystonia |
5.8% |
| Weight Decreased |
5.4% |
| Vomiting |
4.4% |
| Sedation |
4.2% |
| Extrapyramidal Disorder |
4.0% |
| Drug Ineffective |
3.6% |
| Death |
3.5% |
| Withdrawal Syndrome |
3.5% |
| Insomnia |
3.2% |
| Vision Blurred |
3.2% |
| Swollen Tongue |
3.0% |
| Malaise |
3.0% |
| Electrocardiogram Qt Prolonged |
2.8% |
| Suicidal Ideation |
2.8% |
| Akathisia |
2.8% |
| Neuroleptic Malignant Syndrome |
2.6% |
|
| Secondary |
| Bipolar Disorder |
21.5% |
| Depression |
15.6% |
| Product Used For Unknown Indication |
9.0% |
| Anxiety |
8.3% |
| Schizophrenia |
7.3% |
| Hypertension |
4.5% |
| Psychotic Disorder |
3.8% |
| Bipolar I Disorder |
3.2% |
| Schizoaffective Disorder |
3.1% |
| Drug Use For Unknown Indication |
2.9% |
| Major Depression |
2.7% |
| Sleep Disorder |
2.4% |
| Affective Disorder |
2.3% |
| Diabetes Mellitus |
2.2% |
| Attention Deficit/hyperactivity Disorder |
2.2% |
| Insomnia |
2.1% |
| Paranoia |
2.0% |
| Mood Swings |
1.7% |
| Blood Cholesterol Increased |
1.6% |
| Mania |
1.5% |
|
| Weight Increased |
17.5% |
| Tremor |
9.5% |
| Tardive Dyskinesia |
8.3% |
| Weight Decreased |
6.8% |
| Somnolence |
6.2% |
| Insomnia |
4.2% |
| Drug Ineffective |
4.1% |
| Suicidal Ideation |
4.1% |
| Vomiting |
3.8% |
| Withdrawal Syndrome |
3.8% |
| Mental Disorder |
3.6% |
| Dyskinesia |
3.5% |
| Thinking Abnormal |
3.5% |
| Swollen Tongue |
3.2% |
| Dystonia |
3.1% |
| Headache |
3.1% |
| Feeling Abnormal |
3.0% |
| Vision Blurred |
3.0% |
| Dry Mouth |
2.9% |
| Psychotic Disorder |
2.9% |
|
| Concomitant |
| Depression |
20.0% |
| Bipolar Disorder |
19.0% |
| Schizophrenia |
9.5% |
| Anxiety |
8.6% |
| Product Used For Unknown Indication |
5.8% |
| Sleep Disorder |
5.7% |
| Insomnia |
4.2% |
| Drug Use For Unknown Indication |
3.6% |
| Pain |
3.5% |
| Psychotic Disorder |
2.6% |
| Smoking Cessation Therapy |
2.5% |
| Hypertension |
2.2% |
| Schizoaffective Disorder |
2.1% |
| Affective Disorder |
1.9% |
| Asthma |
1.6% |
| Agitation |
1.6% |
| Diabetes Mellitus |
1.5% |
| Mental Disorder |
1.4% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Bipolar I Disorder |
1.3% |
|
| Type 2 Diabetes Mellitus |
31.5% |
| Weight Increased |
18.5% |
| Pancreatitis |
7.6% |
| Diabetes Mellitus |
4.9% |
| Tardive Dyskinesia |
4.4% |
| Vomiting |
4.2% |
| Type 1 Diabetes Mellitus |
3.3% |
| Suicidal Ideation |
2.9% |
| Vision Blurred |
2.8% |
| Obesity |
2.6% |
| Suicide Attempt |
2.3% |
| Tremor |
2.2% |
| Urinary Tract Infection |
2.0% |
| Nausea |
1.7% |
| Weight Decreased |
1.6% |
| Rash |
1.5% |
| Somnolence |
1.5% |
| Diabetic Ketoacidosis |
1.4% |
| Drug Ineffective |
1.4% |
| Pulmonary Embolism |
1.4% |
|
| Interacting |
| Product Used For Unknown Indication |
12.4% |
| Depression |
11.1% |
| Bipolar Disorder |
9.8% |
| Schizophrenia |
6.9% |
| Mental Disorder |
5.8% |
| Anxiety |
5.3% |
| Hallucination, Auditory |
4.7% |
| Lennox-gastaut Syndrome |
4.7% |
| Obsessive-compulsive Disorder |
4.2% |
| Paranoia |
4.2% |
| Ex-smoker |
3.7% |
| Hallucination, Visual |
3.7% |
| Psychotic Disorder |
3.7% |
| Suicidal Ideation |
3.7% |
| Sleep Disorder |
3.2% |
| Affective Disorder |
2.9% |
| Mania |
2.6% |
| Mood Swings |
2.6% |
| Dyspepsia |
2.4% |
| Insomnia |
2.4% |
|
| Suicidal Ideation |
15.6% |
| Somnolence |
11.1% |
| Drug Interaction |
10.0% |
| Vomiting |
6.7% |
| Withdrawal Syndrome |
6.7% |
| Wrong Technique In Drug Usage Process |
6.7% |
| Mania |
5.6% |
| Serotonin Syndrome |
5.6% |
| Drug Ineffective |
4.4% |
| Tremor |
4.4% |
| Speech Disorder |
3.3% |
| Weight Increased |
3.3% |
| Dystonia |
2.2% |
| Feeling Abnormal |
2.2% |
| Potentiating Drug Interaction |
2.2% |
| Stress |
2.2% |
| Suspiciousness |
2.2% |
| Unevaluable Event |
2.2% |
| White Blood Cell Count Decreased |
2.2% |
| Agranulocytosis |
1.1% |
|
